Peripheral arterial disease in polymyalgia rheumatica

Arthritis Research and Therapy

Volumn 11, Issue 3, 2009, Pages

  Borg, Frances A ^a   Dasgupta, Bhaskar ^a  

^a SOUTHEND UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOCORTICOID; HOMOCYSTEINE;

ARTERIAL WALL THICKNESS; ATHEROMA; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BLOOD VESSEL BIOPSY; CARDIOVASCULAR RISK; CAROTID ARTERY; DISEASE ASSOCIATION; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE SEDIMENTATION RATE; GIANT CELL ARTERITIS; HUMAN; INFLAMMATION; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; FOLLOW UP; LONGITUDINAL STUDY; NOTE; PERIPHERAL VASCULAR DISEASE;

FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; PERIPHERAL VASCULAR DISEASES; POLYMYALGIA RHEUMATICA; VASCULITIS;

EID: 66249099532     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2685     Document Type: Editorial

References (12)

1. Warrington KJ Jarpa E Crowson CS Cooper LT Hunder GG Matteson EL Gabriel SE Increased risk of peripheral arterial disease in polymyalgia rheumatica: A population-based cohort study Arthritis Res Ther 2009, 11:R50. 10.1186/ar2664 19335902
2. Maradit Kremers H Reinalda MS Crowson CS Zinsmeister AR Hunder GG Gabriel SE Direct medical costs of polymyalgia rheumatica Arthritis Rheum 2005, 53:578-584. 10.1002/art.21311 16082650
3. Manzi S Wasko MCM Inflammation-mediated rheumatic diseases and atherosclerosis Ann Rheum Dis 2000, 59:321-325. 1753135 10784507 10.1136/ ard.59.5.321
4. Ridker PM Cushman M Stamfer MJ Tracy RP Hennekens CH Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease Circulation 1998, 97:425-428. 9490235
5. Martinez-Taboada VM Bartolome MJ Fernandez-Gonzalez MD Blanco R Rodriguez-Valverde V Lopez-Hoyos M Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: Influence of corticosteroid therapy Rheumatology 2003, 42:1055-1061. 10.1093/rheumatology/keg293 12730520
6. Maradit Kremers H Nicola LJ Crowson CS Ballman KV Gabriel SE Cardiovascular death in rheumatoid arthritis Arthritis Rheum 2005, 52:722-732. 10.1002/art.20878 15751097
7. Uddhammar A Eriksson A-L Nyström L Stenling R Rantapää-Dahlqvist S Increased mortality due to cardiovascular disease in patients with giant cell arteritis in Northern Sweden J Rheumatol 2002, 29:737-742. 11950015
8. Maradit Kremers H Reinalda MS Crowson CS Davis JM Hunder GG Gabriel SE Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica Arthritis Rheum 2007, 57:279-286. 10.1002/ art.22548 17330277
9. Gonzalez-Juanatey C Lopez-Diaz MJ Martin J Llorca J Gonzalez-Gay MA Atherosclerosis in patients with biopsy-proven giant cell arteritis Arthritis Rheum 2007, 57:1481-1486. 10.1002/art.23114 18050166
10. Nuenninghoff DM Hunder GG Christianson TJH McClelland RL Matteson EL Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis Arthritis Rheum 2003, 48:3522-3531. 10.1002/art.11353 14674004
11. Moosig F Czech N Mehl C Hanze E Zeuner RA Kneba M Schroder JO Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: A quantitative PET study Ann Rheum Dis 2004, 63:870-873. 1755055 15194587 10.1136/ard.2003.011692
12. Weyand CM Hicok KC Hunder GG Goronzy JJ Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis Ann Int Med 1994, 121:484-491. 8067646